PRDM16 rs2183836: Retinal Thickness and Vision Genetics
The single-nucleotide polymorphism rs2183836 is an intronic variant located within the PRDM16 gene on chromosome 1. Genome-wide association studies have fine-mapped this genetic marker to subtle differences in ocular anatomy, specifically variations in age-related retinal and macular thickness. Carrying specific alleles at this site reflects minor statistical shifts in retinal morphology across populations rather than a diagnosis of visual impairment.
What each genotype means
Typical retinal thickness profile
You carry two copies of the C allele at rs2183836 in the PRDM16 locus. In genome-wide association studies, this baseline genotype is associated with standard retinal and macular thickness measurements rather than the reduced thickness trends linked to the alternative allele. This variant represents a subtle statistical factor across populations rather than a diagnostic marker for eye disease.
Carried by approximately 40% to 45% of individuals of European ancestry and is also common in other global populations.
Slightly altered retinal thickness
You carry one copy of the T allele associated with variations in retinal and macular morphology. Large-scale population studies show that heterozygous carriers demonstrate modest, subclinical shifts in macular layer thickness compared to homozygous C carriers. This finding reflects normal biological variation in eye structure and does not indicate an eye disorder on its own.
Carried by roughly 45% of people of European descent, representing the most common genotype group.
Reduced macular thickness tendency
You carry two copies of the T allele at this PRDM16 genomic locus. In published ophthalmic genetic studies, having two copies of this variant is statistically correlated with measurable reductions in retinal and macular layer thickness. Because this variant exerts modest polygenic effects alongside many lifestyle and environmental factors, it does not diagnose any retinal condition or vision impairment.
Carried by roughly 10% to 15% of individuals in European populations, where the minor allele frequency is approximately 0.35.
Genomic Location and Context
The genetic variant rs2183836 is a single-nucleotide polymorphism situated within an intron of the PRDM16 locus on the short arm of chromosome 1. In dbSNP records, this marker represents a single base-pair substitution between adenine and guanine alleles. Because it resides in a non-coding region, rs2183836 does not alter the amino acid sequence of the resulting protein directly. Instead, research indicates that non-coding intronic variants frequently influence transcriptional dynamics, acting as expression quantitative trait loci or tagging broader regulatory haplotypes. Genomic fine-mapping analyses place this variant in a region implicated in structural ocular phenotypes. While its physical location within the gene is precisely cataloged, determining its exact regulatory mechanism in eye tissues remains an ongoing area of scientific inquiry.
The Biological Role of PRDM16
The PRDM16 gene encodes PR domain-containing protein 16, a zinc finger transcription factor and epigenetic regulator that modulates gene expression programs across multiple tissue types. While extensively recognized for controlling cell fate decisions in adipose tissue development and cardiac morphogenesis, PRDM16 is also expressed throughout neural and vascular systems. In the visual system, experimental models demonstrate that PRDM16 participates in retinal vascular patterning and arterial maturation. By interacting with chromatin-modifying enzymes, the transcription factor orchestrates cellular survival, differentiation, and structural homeostasis. Consequently, natural genetic variations within or near PRDM16 that subtly alter its regulatory activity can influence the development and microstructural maintenance of retinal cell layers over the human lifespan.
Association with Retinal and Macular Thickness
Large-scale genome-wide association studies (GWAS) measuring structural ocular characteristics via optical coherence tomography (OCT) have identified rs2183836 as a moderate-evidence risk variant for variation in retinal thickness. Specifically, fine-mapping studies correlate this locus with differences in central macular thickness and the integrity of inner retinal layers. Optical coherence tomography provides non-invasive, micrometer-resolution cross-sectional imaging of the retina, allowing researchers to detect subtle shifts attributable to polygenic influences. While rs2183836 demonstrates statistically robust associations with these quantitative anatomical measurements, its individual effect size is modest. It does not indicate retinal detachment or severe ocular pathology on its own, but rather contributes incrementally to an individual's baseline retinal architecture alongside numerous other polygenic loci and environmental factors.
Population Distribution and Ancestry Differences
Allele distributions for rs2183836 demonstrate measurable variation across global populations. In individuals of European ancestry, the minor allele frequency is approximately 0.35, making both heterozygous and homozygous states relatively common in these cohorts. In other ancestral backgrounds, including East Asian and African populations, the frequency of the alternate allele can differ, which influences how informative the marker is when calculating polygenic models. Because the vast majority of ocular OCT association studies have historically evaluated cohorts of European descent, the direct statistical weight of rs2183836 may not translate identically across different ancestries due to variable linkage disequilibrium patterns and distinct background haplotype structures.
Clinical Interpretation and Practical Limitations
It is critical for consumers and patients to understand the boundaries of what rs2183836 can reveal. This variant is a statistical marker for subtle morphological traits, not a clinical diagnostic test for blindness, macular degeneration, or glaucoma. Carrying one or two copies of the statistical risk allele does not mean an individual will develop vision loss, nor does an alternate genotype ensure immunity from ocular disorders. Clinicians do not use rs2183836 status to direct medical therapies or alter surgical decisions. Routine, comprehensive eye examinations by an optometrist or ophthalmologist remain the standard method for evaluating retinal health, visual acuity, and structural changes over time.
How common is this variant?
The minor allele frequency for rs2183836 is approximately 0.35 in European populations, with alternate allele frequencies showing variability across non-European ancestral groups.
Frequently asked questions
Does having the rs2183836 variant mean I will lose my vision?
No, carrying the rs2183836 variant does not mean you will lose your vision. This genetic marker is associated with minor variations in the physical thickness of retinal tissue measured on research imaging scans, not clinical blindness or sudden vision deterioration.
Can an eye doctor detect the effects of rs2183836 during an exam?
An eye care professional cannot visually differentiate your genetic variant status during a regular examination. While optical coherence tomography (OCT) devices measure retinal and macular thickness in micrometers, individual thickness measurements are influenced by age, sex, refractive error, and overall health far more than any single genetic variant.
Is PRDM16 rs2183836 linked to age-related macular degeneration?
While rs2183836 is fine-mapped to retinal thickness traits that are anatomically relevant to the macula, it is not considered one of the primary high-impact causal determinants for age-related macular degeneration (AMD), which are largely dominated by loci such as CFH and ARMS2/HTRA1.
What actionable steps should I take if my genotype shows the risk allele?
There are no specific medical interventions, medications, or specialized dietary plans indicated based solely on this genotype. The most effective action you can take to protect your vision is to schedule routine, dilated comprehensive eye exams and maintain overall cardiovascular health.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2183836?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29